Cerebral vasculitis is inflammation of the blood vessels in the brain. The inflamed vessel walls thicken, narrow, and sometimes become blocked entirely, cutting off blood flow to brain tissue. When areas of the brain lose their blood supply, the result can be stroke, cognitive decline, or a range of neurological symptoms that often mimic other conditions, making this one of the more difficult diagnoses in neurology.
How Blood Vessel Inflammation Damages the Brain
The immune system drives the damage. Certain white blood cells, particularly T cells, become activated and infiltrate the walls of small arteries in the brain. These immune cells release enzymes that break down the structural proteins holding vessel walls together. At the same time, the body’s complement system, a separate branch of immune defense, becomes dysregulated and adds to the inflammatory attack.
As inflammation thickens the vessel walls, the channel for blood flow narrows. Endothelial cells lining the inside of the vessel stop functioning normally, which promotes clotting and further obstruction. The downstream brain tissue, now starved of oxygen and nutrients, begins to die. This process can produce small, scattered areas of tissue death (infarction) or, less commonly, bleeding when a weakened vessel wall ruptures. The damage tends to accumulate over weeks to months rather than striking all at once, which is one reason the condition is so often misdiagnosed early on.
Primary vs. Secondary Types
Doctors divide cerebral vasculitis into two broad categories based on where the disease originates.
Primary cerebral vasculitis (also called primary angiitis of the central nervous system) arises on its own, without any other disease driving it. Its cause is unknown. One recognized subtype involves an immune reaction against a protein called amyloid-beta that builds up in brain blood vessels. This subtype triggers inflammation in the membranes surrounding the brain and in the brain tissue itself, accelerating vessel blockage and ischemic injury.
Secondary cerebral vasculitis develops as a consequence of another condition. The list of potential triggers is long:
- Autoimmune diseases: Lupus, Behçet’s syndrome, Sjögren’s syndrome, and several forms of systemic vasculitis that can extend into the brain.
- Viral infections: Varicella-zoster virus (the virus behind chickenpox and shingles) is one of the most common infectious triggers and frequently affects a major artery supplying the deep brain structures, leading to strokes in the basal ganglia. HIV, hepatitis C, Epstein-Barr virus, cytomegalovirus, and West Nile virus are also recognized causes.
- Bacterial infections: Tuberculosis, syphilis, Lyme disease, and certain pneumonia-causing bacteria can all inflame brain vessels.
- Drugs: Cocaine use can produce a vasculopathy that closely resembles vasculitis on imaging.
Identifying whether the vasculitis is primary or secondary matters because treatment differs. Secondary forms may improve when the underlying infection or autoimmune disease is controlled, while primary forms require direct immunosuppression.
Common Symptoms
Cerebral vasculitis rarely announces itself with a single dramatic event. More often, symptoms build gradually and fluctuate, which is part of what makes it so tricky to recognize. Headache is one of the most frequent complaints, often persistent and unlike a person’s usual headaches. Cognitive changes are common too: difficulty concentrating, memory lapses, mental fogginess, or personality shifts that friends and family notice before the patient does.
Because the inflammation can affect vessels anywhere in the brain, the specific neurological symptoms vary widely. Some people develop weakness or numbness on one side of the body, similar to a stroke. Others experience seizures, vision changes, difficulty speaking, or problems with coordination. When the condition progresses without treatment, symptoms tend to worsen in a stepwise fashion, with each new episode reflecting damage to a different area of the brain.
How It’s Diagnosed
There is no single test that confirms cerebral vasculitis, and the diagnosis often requires piecing together multiple findings.
Brain Imaging
MRI is typically the first step. It can reveal scattered areas of restricted blood flow or small strokes in patterns that don’t match the territory of a single artery, a clue that something is affecting multiple vessels. A specialized form of MRI called vessel wall imaging has become increasingly important. In vasculitis, the walls of affected arteries show circumferential (all-the-way-around) thickening and enhancement after contrast dye is injected. This distinguishes vasculitis from other causes of narrowed arteries.
Angiography, either through MRI-based techniques or conventional catheter angiography, can show multiple narrowings (stenoses) along brain arteries. The vessels may appear stiffened, with kinking or irregular caliber changes. However, these findings are not specific to vasculitis and can appear in other conditions.
Spinal Fluid Analysis
A lumbar puncture often shows signs of inflammation in the cerebrospinal fluid, such as elevated protein levels and an increased number of white blood cells. These findings support the diagnosis but don’t prove it on their own. In the primary form, analysis of spinal fluid has revealed evidence of dysregulated complement activation, pointing to an overactive immune response within the central nervous system.
Brain Biopsy
Biopsy remains the most definitive diagnostic tool, but it has significant limitations. A surgeon removes a small piece of brain tissue and its overlying membrane, and a pathologist looks for inflammation in the vessel walls. The problem is sampling: vasculitis can be patchy, and the biopsy may miss affected areas entirely. In one large review of published cases, about 14% of patients with biopsy-confirmed vasculitis had completely normal angiography, and roughly 11% of patients with abnormal angiograms had normal biopsies. When angiography did suggest vasculitis, a biopsy was actually more than twice as likely to come back normal than to show vasculitis. This low agreement between the two tests reflects the reality that vasculitis can affect different-sized vessels, and no single test catches all of them.
Distinguishing It From RCVS
Reversible cerebral vasoconstriction syndrome (RCVS) is the condition most commonly confused with cerebral vasculitis because both cause narrowing of brain arteries on imaging. The distinction matters enormously: RCVS typically resolves on its own within three months, while vasculitis requires prolonged immunosuppressive treatment.
Several features help tell them apart. RCVS usually begins with a sudden, explosive “thunderclap” headache, while vasculitis headaches tend to build gradually. Spinal fluid in RCVS is usually near-normal, whereas vasculitis commonly shows inflammatory changes. The most promising differentiator is vessel wall MRI. In vasculitis, the artery walls light up with contrast enhancement, reflecting active inflammation. In RCVS, the walls may be thickened but do not enhance. In a study comparing the two conditions, all patients who lacked vessel wall enhancement had complete reversal of their arterial narrowing within three months (consistent with RCVS), while those with enhancement had persistent or worsening narrowing over a median follow-up of 17 months.
Treatment and What to Expect
Treatment for primary cerebral vasculitis involves suppressing the immune system aggressively enough to stop the inflammatory attack on blood vessels, then gradually stepping down to a gentler long-term regimen.
The initial phase, called induction, typically lasts four to six months. It combines high-dose steroids with a powerful immune-suppressing medication. The goal is to halt active inflammation and prevent new strokes or neurological damage. Once symptoms stabilize and imaging shows improvement, treatment shifts to a maintenance phase using lower-dose steroids and a less intensive immunosuppressive drug. This maintenance phase generally continues for about a year, sometimes longer depending on how the disease behaves.
For secondary cerebral vasculitis, treating the underlying cause is essential. If a viral infection like varicella-zoster is driving the inflammation, antiviral therapy is the priority. If an autoimmune disease is responsible, managing that condition often brings the brain vessel inflammation under control as well.
Long-Term Outlook
Cerebral vasculitis is serious, but outcomes have improved significantly with modern treatment. Five-year survival rates for vasculitis in general rose from about 70% in the 1990s to around 80% in the 2000s, largely because better diagnostic tools now catch the disease earlier. For cerebral vasculitis specifically, prognosis depends heavily on how quickly treatment begins, which type of vessels are affected, and whether the disease is primary or secondary.
Relapses are a real concern. Some people respond well to initial treatment and remain in long-term remission, while others experience flares that require retreatment. Ongoing monitoring with repeat imaging and clinical assessments is a standard part of follow-up care. The cumulative damage from inflammation before and during treatment can leave lasting effects on cognition, energy levels, and neurological function, so rehabilitation and cognitive support play an important role in recovery for many patients.